You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 12, December 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evoked Potentials to Test a Treatment of Chronic Multiple Sclerosis

David C. Anderson, MD; Gerald E. Slater, MD; Robert Sherman, PhD; Milton G. Ettinger, MD

Arch Neurol. 1987;44(12):1232-1236.


Abstract

• Multimodal evoked potentials (EPs) were obtained serially in 57 patients with multiple sclerosis enrolled in a double-blind, controlled study of hyperbaric oxygen. We encountered drawbacks in the use of EPs in monitoring effects of a treatment for chronic multiple sclerosis. Limitations include a relatively arduous testing protocol and the significant occurrence of ambiguous and frankly unreproducible results. Test/retest variability is large in stable patients. There is poor correspondence between EP changes and changes of clinical function as well as among EP modalities. Whether EP measurements ultimately prove to be useful in testing new therapies awaits the development of a truly effective treatment, the effects of which can be shown despite these factors and limitations.



Author Affiliations

From the Departments of Neurology, Hennepin County Medical Center and the University of Minnesota Medical School, Minneapolis.


Footnotes

Accepted for publication June 29, 1987.

Reprint requests to Department of Neurology, Hennepin County Medical Center, 701 Park Ave S, Minneapolis, MN 55414 (Dr Anderson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis
Weinstock-Guttman et al.
Mult Scler 2003;9:529-534.
ABSTRACT  

Visual and motor evoked potentials in the course of multiple sclerosis
Fuhr et al.
Brain 2001;124:2162-2168.
ABSTRACT | FULL TEXT  

Ocular microtremor (OMT): a new neurophysiological approach to multiple sclerosis
Bolger et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:639-642.
ABSTRACT | FULL TEXT  

Measuring evoked responses in multiple sclerosis
Comi et al.
Mult Scler 1999;5:263-267.
ABSTRACT  

Neurophysiological and cognitive markers of disease evolution in multiple sclerosis
Comi et al.
Mult Scler 1998;4:260-265.
ABSTRACT  

Evoked Potentials As Outcome Measures in Multiple Sclerosis
Giesser
Neurorehabil Neural Repair 1993;7:99-104.
 

Evoked Potentials During Multiple Sclerosis Therapeutic Trials
Nuwer et al.
Arch Neurol 1989;46:11-12.
ABSTRACT  

Evoked Potentials During Multiple Sclerosis Therapeutic Trials-Reply
Anderson and Sherman
Arch Neurol 1989;46:12-13.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.